E. Banki, Zs Hajna, A. Kemeny, B. Botz, P. Nagy, K. Bolcskei, G. Toth, D. Reglodi & Zs Helyes. (2014) The selective PAC1 receptor agonist maxadilan inhibits neurogenic vasodilation and edema formation in the mouse skin. Neuropharmacology 85, pages 538-547.
Crossref
Robert J. Lee, Bei Chen, Laurel Doghramji, Nithin D. Adappa, James N. Palmer, David W. Kennedy & Noam A. Cohen. (2013) Vasoactive intestinal peptide regulates sinonasal mucociliary clearance and synergizes with histamine in stimulating sinonasal fluid secretion. The FASEB Journal 27:12, pages 5094-5103.
Crossref
William Rea & Kalpana Patel. 2010. Reversibility of Chronic Degenerative Disease and Hypersensitivity, Volume 1. Reversibility of Chronic Degenerative Disease and Hypersensitivity, Volume 1
185
335
.
Yuki Ohmori, Satomi Onoue, Kosuke Endo, Asami Matsumoto, Shinya Uchida & Shizuo Yamada. (2006) Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration. Life Sciences 79:2, pages 138-143.
Crossref
David A. Groneberg, Klaus F. Rabe & Axel Fischer. (2006) Novel concepts of neuropeptide-based drug therapy: Vasoactive intestinal polypeptide and its receptors. European Journal of Pharmacology 533:1-3, pages 182-194.
Crossref
D. A. Groneberg, D. Quarcoo, N. Frossard & A. Fischer. (2004) Neurogenic mechanisms in bronchial inflammatory diseases. Allergy 59:11, pages 1139-1152.
Crossref
David A. Groneberg, Jochen Springer & Axel Fischer. (2001) Vasoactive Intestinal Polypeptide as Mediator of Asthma. Pulmonary Pharmacology & Therapeutics 14:5, pages 391-401.
Crossref
Amr El-Shazly, Keisuke Masuyama, Noriaki Tsunoda, Masao Eura & Takeru Ishikawa. (2000) Non-specific activation of human eosinophil functional responses by vasoactive intestinal peptide. Allergology International 49:1, pages 19-26.
Crossref
James & Nijkamp. (2001) Neuro‐immune interactions in the lung. Clinical & Experimental Allergy 29:10, pages 1309-1319.
Crossref
Dietrich Reinhardt. 1999. Asthma bronchiale im Kindesalter. Asthma bronchiale im Kindesalter
43
131
.
David A. Schwartz & Michael W. Peterson. (1998) Occupational lung disease. Disease-a-Month 44:2, pages 41-84.
Crossref
Dietrich ReinhardtDietrich Reinhardt. 1996. Asthma bronchiale im Kindesalter. Asthma bronchiale im Kindesalter
37
110
.
D. Nohr, L.E. Eiden & E. Weihe. (1995) Coexpression of vasoactive intestinal peptide, calcitonin gene-related peptide and substance P immunoreactivity in parasympathetic neurons of the rhesus monkey lung. Neuroscience Letters 199:1, pages 25-28.
Crossref
Peter J. Barnes. 1994. Airways Smooth Muscle. Airways Smooth Muscle
209
259
.
Rolf Uddman, Lars Olaf Cardell, Anders Luts & Frank Sundler. 1994. Airways Smooth Muscle. Airways Smooth Muscle
143
156
.
María-Carmen F. Iriate, JoséL. Díaz-Juárez, Eduardo Arilla, Rodolfo Pascual, Julio Cortijo, Charles Advenier, Juan C. Prieto & Esteban J. Morcillo. (1993) Effects of sensitization on vasoactive intestinal polypeptide-induced relaxation and its concentration and binding in guinea-pig airways. European Journal of Pharmacology 250:2, pages 295-302.
Crossref
J. Mullol & C. Picado. (1993) Neuropéptidos. Su papel en la fisiopatología respiratoria humana. Archivos de Bronconeumología 29:1, pages 27-36.
Crossref
Peter J. Barnes, James N. Baraniuk & Maria G. Belvisi. (1991) Neuropeptides in the Respiratory Tract: Part I. American Review of Respiratory Disease 144:5, pages 1187-1198.
Crossref
I. Lemaire, S. Jones & M.F. Khan. (1991) Bombesin-like peptides in alveolar macrophage: Increased release in pulmonary inflammation and fibrosis. Neuropeptides 20:1, pages 63-72.
Crossref
Judith L. Black. (1991) Control of Human Airway Smooth Muscle. American Review of Respiratory Disease 143:3_pt_2, pages S11-S12.
Crossref
Alison A. Hislop, John Wharton, Kim M. Allen, Julia M. Polak & Sheila G. Haworth. (1990) Immunohistochemical Localization of Peptide-containing Nerves in Human Airways: Age-related Changes. American Journal of Respiratory Cell and Molecular Biology 3:3, pages 190-198.
Crossref
Stephen G. Farmer & James Togo. (1990) Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation. British Journal of Pharmacology 100:1, pages 73-78.
Crossref
James N. Baraniuk & Michael A. Kaliner. (1990) Neuropeptides in the Upper and Lower Respiratory Tracts. Immunology and Allergy Clinics of North America 10:2, pages 383-407.
Crossref
J.Paul Seale. (1990) Chemical targeting of drug therapy in asthma and airways disease. Advanced Drug Delivery Reviews 5:1-2, pages 73-92.
Crossref
Sally Ann Provow & Gönül Veliçelebi. (1990) Limited proteolysis of the vasoactive intestinal peptide receptor: comparison of its folded structure in the membrane-bound and detergent-solubilized states. Regulatory Peptides 28:1, pages 71-82.
Crossref
Peter J. Barnes. (1990) Neural control of airway function: New perspectives. Molecular Aspects of Medicine 11:5, pages 351-423.
Crossref
Marina Pretolani, Pablo Ferrer-Lopez & B.Boris Vargaftig. (1989) From anti-asthma drugs to PAF-acether anatagonism and back. Biochemical Pharmacology 38:9, pages 1373-1384.
Crossref
R. MATRAN, K. ALVING, C.‐R. MARTLING, J.S. LACROIX & J.M. LUNDBERG. (2008) Effects of neuropeptides and capsaicin on tracheobronchial blood flow of the pig. Acta Physiologica Scandinavica 135:3, pages 335-342.
Crossref
P. J. Barnes. 1989. Regulatory Peptides. Regulatory Peptides
317
333
.
Sami I. Said. 1989. Airway Smooth Muscle in Health and Disease. Airway Smooth Muscle in Health and Disease
55
76
.
S Patthi, S Simerson & G Veliçelebi. (1988) Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.. Journal of Biological Chemistry 263:36, pages 19363-19369.
Crossref
PETER HEINZ-ERIAN & SAMI I. SAID. (1988) Vasoactive Intestinal Peptide as a Regulator of Exocrine Function and as a Possible Factor in Cystic Fibrosis. Annals of the New York Academy of Sciences 527:1 Vasoactive In, pages 568-573.
Crossref
SAMI I. SAID. (1988) Vasoactive Intestinal Peptide in the Lung. Annals of the New York Academy of Sciences 527:1 Vasoactive In, pages 450-464.
Crossref
GÖNÜL VELIÇELEBI, SARASWATHI PATTHI, SALLY PROVOW, MICHAEL AKONG & SUSAN SIMERSON. (1988) Structural Characterization of Vasoactive Intestinal Peptide Receptors from Rat Lung Membranes. Annals of the New York Academy of Sciences 527:1 Vasoactive In, pages 266-281.
Crossref
P. Geppetti, M. De Rossi, M. C. Mione, D. Renzi & F. Amenta. (1988) Age-related changes in vasoactive intestinal polypeptide levels and distribution in the rat lung. Journal of Neural Transmission 74:1, pages 1-10.
Crossref
P.J. Barnes. (1988) Neuropeptides and airway smooth muscle. Pharmacology & Therapeutics 36:1, pages 119-129.
Crossref
Peter J. Barnes. (1987) Neuropeptides in Human Airways: Function and Clinical Implications. American Review of Respiratory Disease 136:6_pt_2, pages S77-S83.
Crossref
Sami I. Said. (1987) Influence of Neuropeptides on Airway Smooth Muscle. American Review of Respiratory Disease 136:6_pt_2, pages S52-S58.
Crossref
Jan M. Lundberg, Lars Lundblad, Claes-Roland Martling, Alois Saria, Per Stjärne & Anders Änggård. (1987) Coexistence of Multiple Peptides and Classic Transmitters in Airway Neurons: Functional and Pathophysiologic Aspects. American Review of Respiratory Disease 136:6_pt_2, pages S16-S22.
Crossref
S Patthi, M Akong & G Veliçelebi. (1987) Hydrodynamic characterization of vasoactive intestinal peptide receptors extracted from rat lung membranes in Triton X-100 and n-octyl-beta-D-glucopyranoside.. Journal of Biological Chemistry 262:32, pages 15740-15745.
Crossref
Robert Day, Simon Lemaire, Denis Nadeau, Ingegerd Keith & Irma Lemaire. (1987) Changes in Autacoid and Neuropeptide Contents of Lung Cells in Asbestos-induced Pulmonary Fibrosis. American Review of Respiratory Disease 136:4, pages 908-915.
Crossref
P. J. Barnes. (1987) Regulatory peptides in the respiratory system. Experientia 43:7, pages 832-839.
Crossref
Peter J. Barnes. (1987) Autonomic Control of Airway Function in Asthma. Chest 91:5, pages 45S-48S.
Crossref
Peter J. Barnes, Alain Cadieux, Jill R. Carstairs, Barry Greenberg, Julia M. Polak & Kerry Rhoden. (2012) Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography. British Journal of Pharmacology 89:1, pages 157-162.
Crossref
J. Richardson. 1985. Peptide Hormones in Lung Cancer. Peptide Hormones in Lung Cancer
29
33
.
R. Day, I. Lemaire & S. Lemaire. 1985. In Vitro Effects of Mineral Dusts. In Vitro Effects of Mineral Dusts
337
343
.
John F. Burka & Maan H. Saad. (1984) Bronchodilator-mediated relaxation of normal and ovalbumin-sensitized guinea-pig airways: lack of correlation with lung adenylate cyclase activation. British Journal of Pharmacology 83:3, pages 645-655.
Crossref
P J Barnes. (1984) The third nervous system in the lung: physiology and clinical perspectives.. Thorax 39:8, pages 561-567.
Crossref
Sami I. Said. (1984) Vasoactive intestinal polypeptide (VIP): Current status. Peptides 5:2, pages 143-150.
Crossref
Stephen J. Coles, K. R. Bhaskar, Donna Defeudis O'Sullivan, Kenneth H. Neill & Lynne M. Reid. 1984. Ciba Foundation Symposium 109 - Mucus and Mucosa. Ciba Foundation Symposium 109 - Mucus and Mucosa
40
60
.